IRSp53 regulates dendritic spine density and is associated with neurological diseases which are potentially linked to dendritic spine initiation defects, namely ASD [130,131,132], schizophrenia [109,133], and attention-deficit/hyperactivity disorder (ADHD) [134,135]. This evidence concerns the gene BAIAP2 and attention deficit-hyperactivity disorder.